⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIOA News
BioAge Labs, Inc. Common Stock
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
prnewswire.com
LCTX
FATE
GERN
BIOA
A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach
prnewswire.com
BIOA
CRSP
VRTX
VYGR
Form 8-K
sec.gov
BIOA
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
BIOA
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
globenewswire.com
BIOA
BioArctic publishes the Annual Report and Sustainability Report for 2025 USA - English USA - English
prnewswire.com
BIOA
BioArctic publishes the Annual Report and Sustainability Report for 2025
prnewswire.com
BIOA
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
globenewswire.com
BIOA
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
BIOA
The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB USA - English USA - English
prnewswire.com
BIOA